Location: In-person at Stanford and virtual

Please check back for updates on speakers, agenda, and registration information.

Welcome to the 2025 Stanford Drug Discovery Symposium. This event has become a cornerstone in the drug discovery community for networking and collaboration. It offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate two days of exciting talks and discussions, including the return of our poster session. We look forward to welcoming you to Stanford for SDDS 2025.

Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute

Participants

Carolyn Bertozzi, PhD

Nobel Laureate 2022
Baker Family Director of Stanford ChEM-H

Patrizia Cavazzoni, MD

Director, Center for Drug Evaluation and Resarch Food and Drug Administration

Karen Knudsen, MBA, PhD

CEO, American Cancer Society & American Cancer Society Cancer Action Network

Stephen Quake, D.Phil

Head of Science, Chan Zuckerberg Initiative

Robert Blum, MBA

President and CEO, Cytokinetics

Aida Habtezion, MD

Chief Medical Officer and Head of Worldwide Medical and Security, Pfizer

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, Food and Drug Administration

John Reed, MD, PhD

Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson

Rob Califf, MD

Commissioner, U.S. Food and Drug Administration

Stephen Hoge, MD

President, Moderna

Andrew Plump, MD, PhD

President of Research and Development, Takeda

Lifetime Achievement Awardees

TBD

Agenda

TBD

Event Program & Poster

TBD

FAQs

Foundation Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Media Partners

Organizers

Amanda Chase, PhD

Associate Director of Strategic Research Development
Stanford Cardiovascular Institute

Kuldev Singh, MD

Professor of Ophthalmology
Stanford University School of Medicine

Sanjay Malhotra, PhD

Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU

Joseph Wu, MD, PhD

Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine

Mark Mercola, PhD

Professor of Medicine
Stanford University School of Medicine
 

Francesca Mae G. Tongco, MS-HCA

Project Coordinator
Stanford Cardiovascular Institute


For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.